BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 33633408)

  • 1. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity.
    Zhou S; Butler-Laporte G; Nakanishi T; Morrison DR; Afilalo J; Afilalo M; Laurent L; Pietzner M; Kerrison N; Zhao K; Brunet-Ratnasingham E; Henry D; Kimchi N; Afrasiabi Z; Rezk N; Bouab M; Petitjean L; Guzman C; Xue X; Tselios C; Vulesevic B; Adeleye O; Abdullah T; Almamlouk N; Chen Y; Chassé M; Durand M; Paterson C; Normark J; Frithiof R; Lipcsey M; Hultström M; Greenwood CMT; Zeberg H; Langenberg C; Thysell E; Pollak M; Mooser V; Forgetta V; Kaufmann DE; Richards JB
    Nat Med; 2021 Apr; 27(4):659-667. PubMed ID: 33633408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-ancestry fine mapping implicates OAS1 splicing in risk of severe COVID-19.
    Huffman JE; Butler-Laporte G; Khan A; Pairo-Castineira E; Drivas TG; Peloso GM; Nakanishi T; ; Ganna A; Verma A; Baillie JK; Kiryluk K; Richards JB; Zeberg H
    Nat Genet; 2022 Feb; 54(2):125-127. PubMed ID: 35027740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single nucleotide variants in the
    Chávez-Vélez E; Álvarez-Nava F; Torres-Vinueza A; Balarezo-Díaz T; Pilataxi K; Acosta-López C; Peña IZ; Narváez K
    Front Cell Infect Microbiol; 2024; 14():1322882. PubMed ID: 38694517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study.
    Butler-Laporte G; Nakanishi T; Mooser V; Morrison DR; Abdullah T; Adeleye O; Mamlouk N; Kimchi N; Afrasiabi Z; Rezk N; Giliberti A; Renieri A; Chen Y; Zhou S; Forgetta V; Richards JB
    PLoS Med; 2021 Jun; 18(6):e1003605. PubMed ID: 34061844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene.
    Magusali N; Graham AC; Piers TM; Panichnantakul P; Yaman U; Shoai M; Reynolds RH; Botia JA; Brookes KJ; Guetta-Baranes T; Bellou E; Bayram S; Sokolova D; Ryten M; Sala Frigerio C; Escott-Price V; Morgan K; Pocock JM; Hardy J; Salih DA
    Brain; 2021 Dec; 144(12):3727-3741. PubMed ID: 34619763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries.
    Banday AR; Stanifer ML; Florez-Vargas O; Onabajo OO; Papenberg BW; Zahoor MA; Mirabello L; Ring TJ; Lee CH; Albert PS; Andreakos E; Arons E; Barsh G; Biesecker LG; Boyle DL; Brahier MS; Burnett-Hartman A; Carrington M; Chang E; Choe PG; Chisholm RL; Colli LM; Dalgard CL; Dude CM; Edberg J; Erdmann N; Feigelson HS; Fonseca BA; Firestein GS; Gehring AJ; Guo C; Ho M; Holland S; Hutchinson AA; Im H; Irby L; Ison MG; Joseph NT; Kim HB; Kreitman RJ; Korf BR; Lipkin SM; Mahgoub SM; Mohammed I; Paschoalini GL; Pacheco JA; Peluso MJ; Rader DJ; Redden DT; Ritchie MD; Rosenblum B; Ross ME; Anna HPS; Savage SA; Sharma S; Siouti E; Smith AK; Triantafyllia V; Vargas JM; Vargas JD; Verma A; Vij V; Wesemann DR; Yeager M; Yu X; Zhang Y; Boulant S; Chanock SJ; Feld JJ; Prokunina-Olsson L
    Nat Genet; 2022 Aug; 54(8):1103-1116. PubMed ID: 35835913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.
    Anisul M; Shilts J; Schwartzentruber J; Hayhurst J; Buniello A; Shaikho Elhaj Mohammed E; Zheng J; Holmes M; Ochoa D; Carmona M; Maranville J; Gaunt TR; Emilsson V; Gudnason V; McDonagh EM; Wright GJ; Ghoussaini M; Dunham I
    Elife; 2021 Aug; 10():. PubMed ID: 34402426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of the protective OAS1 rs10774671-G allele against severe COVID-19 in Moroccans: implications for a North African Neanderthal connection.
    Yousfi FZE; Haroun AE; Nebhani C; Belayachi J; Askander O; Fahime EE; Fares H; Ennibi K; Abouqal R; Razine R; Bouhouche A
    Arch Virol; 2024 Apr; 169(5):109. PubMed ID: 38658463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity.
    Zheng J; Zhang Y; Zhao H; Liu Y; Baird D; Karim MA; Ghoussaini M; Schwartzentruber J; Dunham I; Elsworth B; Roberts K; Compton H; Miller-Molloy F; Liu X; Wang L; Zhang H; Smith GD; Gaunt TR
    EBioMedicine; 2022 Jul; 81():104112. PubMed ID: 35772218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prenylated dsRNA sensor protects against severe COVID-19.
    Wickenhagen A; Sugrue E; Lytras S; Kuchi S; Noerenberg M; Turnbull ML; Loney C; Herder V; Allan J; Jarmson I; Cameron-Ruiz N; Varjak M; Pinto RM; Lee JY; Iselin L; Palmalux N; Stewart DG; Swingler S; Greenwood EJD; Crozier TWM; Gu Q; Davies EL; Clohisey S; Wang B; Trindade Maranhão Costa F; Freire Santana M; de Lima Ferreira LC; Murphy L; Fawkes A; Meynert A; Grimes G; ; Da Silva Filho JL; Marti M; Hughes J; Stanton RJ; Wang ECY; Ho A; Davis I; Jarrett RF; Castello A; Robertson DL; Semple MG; Openshaw PJM; Palmarini M; Lehner PJ; Baillie JK; Rihn SJ; Wilson SJ
    Science; 2021 Oct; 374(6567):eabj3624. PubMed ID: 34581622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons.
    Li H; Reksten TR; Ice JA; Kelly JA; Adrianto I; Rasmussen A; Wang S; He B; Grundahl KM; Glenn SB; Miceli-Richard C; Bowman S; Lester S; Eriksson P; Eloranta ML; Brun JG; Gøransson LG; Harboe E; Guthridge JM; Kaufman KM; Kvarnström M; Cunninghame Graham DS; Patel K; Adler AJ; Farris AD; Brennan MT; Chodosh J; Gopalakrishnan R; Weisman MH; Venuturupalli S; Wallace DJ; Hefner KS; Houston GD; Huang AJW; Hughes PJ; Lewis DM; Radfar L; Vista ES; Edgar CE; Rohrer MD; Stone DU; Vyse TJ; Harley JB; Gaffney PM; James JA; Turner S; Alevizos I; Anaya JM; Rhodus NL; Segal BM; Montgomery CG; Scofield RH; Kovats S; Mariette X; Rönnblom L; Witte T; Rischmueller M; Wahren-Herlenius M; Omdal R; Jonsson R; Ng WF; ; Nordmark G; Lessard CJ; Sivils KL
    PLoS Genet; 2017 Jun; 13(6):e1006820. PubMed ID: 28640813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating causal effects of atherogenic lipid-related traits on COVID-19 susceptibility and severity using a two-sample Mendelian randomization approach.
    Yoshikawa M; Asaba K; Nakayama T
    BMC Med Genomics; 2021 Nov; 14(1):269. PubMed ID: 34774031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study.
    He J; Feng D; de Vlas SJ; Wang H; Fontanet A; Zhang P; Plancoulaine S; Tang F; Zhan L; Yang H; Wang T; Richardus JH; Habbema JD; Cao W
    BMC Infect Dis; 2006 Jul; 6():106. PubMed ID: 16824203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Immune Response of
    Gajate-Arenas M; Fricke-Galindo I; García-Pérez O; Domínguez-de-Barros A; Pérez-Rubio G; Dorta-Guerra R; Buendía-Roldán I; Chávez-Galán L; Lorenzo-Morales J; Falfán-Valencia R; Córdoba-Lanús E
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct antiviral roles for human 2',5'-oligoadenylate synthetase family members against dengue virus infection.
    Lin RJ; Yu HP; Chang BL; Tang WC; Liao CL; Lin YL
    J Immunol; 2009 Dec; 183(12):8035-43. PubMed ID: 19923450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OAS1: a multiple sclerosis susceptibility gene that influences disease severity.
    O'Brien M; Lonergan R; Costelloe L; O'Rourke K; Fletcher JM; Kinsella K; Sweeney C; Antonelli G; Mills KH; O'Farrelly C; Hutchinson M; Tubridy N
    Neurology; 2010 Aug; 75(5):411-8. PubMed ID: 20679634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resurrection of 2'-5'-oligoadenylate synthetase 1 (OAS1) from the ancestor of modern horseshoe bats blocks SARS-CoV-2 replication.
    Lytras S; Wickenhagen A; Sugrue E; Stewart DG; Swingler S; Sims A; Jackson Ireland H; Davies EL; Ludlam EM; Li Z; Hughes J; Wilson SJ
    PLoS Biol; 2023 Nov; 21(11):e3002398. PubMed ID: 38015855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OAS1 gene, Spike protein variants and persistent COVID-19-related anosmia: may the olfactory disfunction be a harbinger of future neurodegenerative disease?
    Di Stadio A; Bernitsas E; Ralli M; Severini C; Brenner MJ; Angelini C
    Eur Rev Med Pharmacol Sci; 2022 Jan; 26(2):347-349. PubMed ID: 35113409
    [No Abstract]   [Full Text] [Related]  

  • 19. OAS1 gene haplotype confers susceptibility to multiple sclerosis.
    Fedetz M; Matesanz F; Caro-Maldonado A; Fernandez O; Tamayo JA; Guerrero M; Delgado C; López-Guerrero JA; Alcina A
    Tissue Antigens; 2006 Nov; 68(5):446-9. PubMed ID: 17092260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible effect of OAS1 and TMPRSS6 but not DPP4 and ZNF335 polymorphisms on COVID-19 severity in the Czech population.
    Hubáček JA; Philipp T; Adámková V; Májek O; Dlouhá D; Dušek L
    Cent Eur J Public Health; 2023 Dec; 31(4):235-239. PubMed ID: 38309700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.